A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.

Vanderbilt is testing a device to assist in locating parathyroid glands during surgery.

The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.

A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.

Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people. All

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.